Skip to main content

Table 1 Baseline demographic characteristics, clinical characteristics and use of vitamin/mineral supplements prior to diagnosis, by race, Kaiser Permanente Northern California, 2006-2013 (n = 2,596 a )

From: Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study

 

All (n = 2,596) %

Non-Hispanic White (n = 1,857) %

African American (n = 155) %

Asian (n = 309) %

Hispanic (n = 275) %

P-valueb

Demographic characteristics

 Age

     

<.0001

  <50

18.5

13.0

19.4

39.5

31.3

 

  50-59

26.7

24.8

35.5

30.4

29.8

 

  60-69

31.9

35.2

27.7

22.7

22.9

 

  70+

23.0

27.0

17.4

7.4

16.0

 

 Education

     

<.0001

  High school or less

13.6

11.8

19.4

8.1

28.4

 

  Some college

33.4

35.1

42.6

14.9

37.8

 

  College graduate

28.4

26.7

22.6

49.5

19.6

 

  Post graduate

24.5

26.3

15.5

27.5

14.2

 

Clinical characteristics

 Stage at diagnosis

     

0.13

  I

56.2

57.3

50.3

54.7

54.2

 

  II

33.0

32.2

37.4

35.0

34.2

 

  III

9.6

9.4

9.0

10.0

11.3

 

  IV

1.1

1.2

3.2

0.32

0.36

 

 Hormone-receptor positivity

     

<.0001

  ER-/PR-

15.7

13.9

29.0

17.2

18.2

 

  ER-/PR+

0.12

0.05

0.0

0.0

0.73

 

  ER+/PR-

20.0

21.1

22.6

15.5

16.0

 

  ER+/PR+

64.1

64.8

47.7

67.3

65.1

 

  Unknown

0.15

0.16

0.65

0.0

0.0

 

Use of vitamin/mineral supplements prior to diagnosis

  Any vitamin/mineral

83.6

85.9

82.6

78.3

73.8

<.0001

  Multivitamins

70.0

73.0

66.5

64.7

58.2

<.0001

  Vitamin C

32.3

34.7

27.7

26.5

24.7

0.0003

  Calcium, tums, or antacids with calcium

23.6

25.1

20.6

21.4

17.8

0.03

  Vitamin E

21.9

23.4

22.6

17.2

16.7

0.01

  Vitamin D

15.4

16.0

20.0

10.4

14.5

0.02

  Iron

12.2

11.5

24.5

10.4

12.4

<.0001

  Vitamin B12

9.6

9.4

16.1

6.5

11.3

0.007

  Folic acid (folate)

8.4

8.9

9.7

6.5

6.9

0.36

  Magnesium

5.2

5.7

5.8

1.6

5.5

0.03

  Zinc

4.7

5.2

3.2

2.9

4.0

0.24

  Vitamin A

3.2

3.1

4.5

1.6

4.7

0.13

  Chromium

2.7

2.7

2.6

1.9

4.0

0.49

  Niacin (B3)

2.0

2.2

1.9

1.0

1.8

0.58

  Beta carotene

1.7

2.0

0.6

0.6

1.1

0.19

  Selenium

1.8

2.2

1.9

0.3

1.5

0.16

  Thiamin (B1)

0.8

0.9

0.0

0.6

1.1

0.64

Use of vitamin/mineral supplements after diagnosis

  Any vitamin/mineral

82.0

84.7

79.4

77.3

71.3

<.0001

  Multivitamins

60.8

63.6

51.6

57.6

50.5

<.0001

  Vitamin C

24.7

26.5

18.1

22.3

18.9

0.003

  Calcium, tums, or antacids with calcium

51.8

56.2

38.7

44.0

38.5

<.0001

  Vitamin E

11.6

12.8

7.7

7.8

10.5

0.02

  Vitamin D

43.1

45.4

40

36.2

37.5

0.003

  Iron

7.5

6.9

14.8

7.4

7.0

0.009

  Vitamin B12

13.8

14.6

16.1

10.4

11.3

0.11

  Folic acid (folate)

9.1

10.1

7.1

5.8

7.3

0.04

  Magnesium

13.8

15.6

7.1

10.0

10.2

0.0004

  Zinc

7.6

8.6

5.2

6.5

3.6

0.01

  Vitamin A

3.1

3.2

1.9

2.6

3.3

0.75

  Chromium

3.0

3.2

1.9

2.3

2.9

0.66

  Niacin (B3)

7.4

8.3

5.2

4.5

5.5

0.03

  Beta carotene

1.7

1.9

0.65

1.6

1.5

0.67

  Selenium

3.1

3.5

1.9

1.9

2.2

0.27

  Thiamin (B1)

6.5

7.1

3.9

5.5

5.8

0.31

  1. aAmong Pathways participants with both baseline and 6 month follow up questionnaire.
  2. bCalculated using a chi-squared test.